Aims and Scope

Purpose and Focus

The International Journal of Clinical Virology (IJCV) is dedicated to publishing high-quality scientific content that enhances understanding of viral diseases across clinical, diagnostic, molecular, and therapeutic dimensions. Its principal aim is to serve as a bridge between laboratory research and clinical practice by encouraging communication among virologists, clinicians, epidemiologists, microbiologists, and public health specialists worldwide.

IJCV focuses on studies that provide insights into viral pathogenesis, epidemiology, diagnosis, treatment, and control, with special emphasis on translational research that directly informs patient management and public health interventions.

Scientific Scope

The scope of IJCV is broad and multidisciplinary, encompassing every domain of human, animal, and zoonotic virology. The journal welcomes manuscripts related to the following key thematic areas:

• Molecular Virology: Mechanisms of viral replication, host–virus interactions, genomic and proteomic studies, and molecular evolution of viruses.
• Clinical Virology: Diagnostic virology, antiviral treatment protocols, resistance mechanisms, clinical outcomes, and case-based evidence.
• Viral Epidemiology and Surveillance: Distribution, transmission dynamics, outbreak investigation, and surveillance systems for emerging viruses.
• Diagnostic Technologies: Molecular assays (PCR, qPCR, RT-PCR), serological testing, point-of-care diagnostics, and innovations in laboratory detection methods.
• Vaccine Research: Vaccine design, immunogenicity assessment, population-level efficacy, and adverse event monitoring.
• Antiviral Therapeutics: Drug discovery, pharmacokinetics, resistance profiles, and development of new antiviral agents.
• Viral Immunology: Host immune responses, cytokine signaling, and immunopathogenesis of acute and chronic infections.
• Public Health Virology: Infection control, community interventions, pandemic preparedness, and global health responses.
• Veterinary and Zoonotic Virology: Viral infections transmissible between animals and humans, and One Health approaches.
• Viral Oncology: Cancer-related viruses such as HPV, EBV, HBV, HCV, and HTLV.

Translational and Applied Research

IJCV prioritizes submissions that translate bench-side research into bedside applications. Manuscripts that connect virology with clinical care, diagnostic advancement, or therapeutic innovation are particularly encouraged. Examples include rapid diagnostic implementation studies, clinical trial reports for antivirals, or translational vaccine evaluations.

IJCV supports evidence that transforms viral knowledge into actionable strategies for global health resilience and patient care excellence.

Relevance to Global Health

The journal is positioned at the intersection of science, medicine, and public policy. By publishing content related to viral outbreaks, public-health interventions, and emerging pathogen surveillance, IJCV contributes directly to preparedness and response efforts against pandemics and epidemics.

Recent decades have shown the urgent necessity for international collaboration in virology research. IJCV acts as a vehicle for sharing data, enhancing early warning systems, and promoting open-access exchange among scientists across all continents.

Specialized Focus Areas

IJCV encourages authors to contribute in-depth work across its principal focus domains:

Article Types and Research Methodologies

To accommodate the diverse nature of virology research, IJCV accepts a wide spectrum of article types including:

• Clinical and experimental research studies.
• Meta-analyses and systematic reviews.
• In silico modeling, bioinformatics, and computational virology studies.
• Short communications and methodological innovations.
• Policy briefs and case series addressing global viral challenges.

Manuscripts should demonstrate methodological rigor, transparency in data reporting, and compliance with ethical standards. Studies using human participants or samples must follow appropriate institutional and international guidelines.

Interdisciplinary Collaboration

Virology is inherently interdisciplinary. IJCV supports research integrating immunology, molecular biology, genomics, proteomics, epidemiology, pharmacology, and clinical medicine. The journal encourages authors to highlight the translational significance of their work and its potential implications for diagnostics, vaccines, or therapeutics.

Geographical and Demographic Relevance

The journal welcomes submissions from all geographic regions, emphasizing representation from low- and middle-income countries (LMICs). Such inclusivity ensures diverse perspectives and strengthens global scientific equity. Research covering regional outbreaks, endemic viral diseases, and locally relevant diagnostic or treatment protocols is highly valued.

Why Publish in IJCV?

• Rapid and Fair Peer Review: Streamlined double-blind process ensures quality and timeliness.
• Global Visibility: Indexed in major repositories and search engines for maximum exposure.
• Ethical Publishing: Compliance with COPE, ICMJE, and OASPA principles.
• Permanent Accessibility: Articles archived via Portico and SHERPA/ROMEO-compatible repositories.
• Cross-disciplinary Reach: Integration of clinical and molecular virology communities.

Editorial Commitment

The IJCV editorial team is committed to nurturing a transparent, ethical, and author-friendly publication environment. Manuscripts are handled with confidentiality, impartiality, and respect for intellectual property. Reviewers are selected for expertise, and editorial decisions are guided solely by scientific merit and ethical integrity.

Conclusion

Through its comprehensive Aims and Scope, the International Journal of Clinical Virology fosters scientific advancement in virology and promotes open-access dissemination of discoveries that can protect human and environmental health. The journal acts as both a knowledge repository and a catalyst for innovation in diagnostics, vaccines, and antiviral therapy.

Submit Your Manuscript